D2D venture Astrum Space joins SPAC resurgence with $1 billion deal SpaceNews
Astrum Space Strikes SPAC Deal for D2D Service at $1B Valuation – Via Satellite
Astrum Space Strikes SPAC Deal for D2D Service at $1B Valuation Via Satellite
Satellite Comms Biz To Go Public Via $1B SPAC Merger – Law360
Satellite Comms Biz To Go Public Via $1B SPAC Merger Law360
Pasqal goes public via SPAC merger with $360M in cash – Dealroom
Pasqal goes public via SPAC merger with $360M in cash Dealroom
Pasqal and Bleichroeder Acquisition Corp. II Complete Business Combination
Pasqal Holding SA expects its ordinary shares to begin trading on Nasdaq under the ticker symbol “PSQL” on August 28th
First Financial Corporation and First Illinois Corporation Sign Merger Agreement
Transaction Strengthens First Financial’s Illinois Franchise Through Addition of Hickory Point Bank and Trust
Transaction Strengthens First Financial’s Illinois Franchise Through Addition of Hickory Point Bank and Trust
Avante Announces Timing of Fiscal First Quarter Investor Webinar
TORONTO, Ontario, Aug. 27, 2026 (GLOBE NEWSWIRE) — Avante Corp. (TSX.V: XX) (OTC: ALXXF) (“Avante” or the “Company”), a global provider of technology enabled security solutions and services, is pleased to announce that the Company will host an investor webinar to provide a corporate update on Monday, August 31, 2026, at 1:00 pm ET (10:00 am PT) to discuss its fiscal first quarter results for the period ending June 30, 2026. The call will be hosted by: Emmanuel Mounouchos, CEO, Chairman, and Founder of Avante, and Raj Kapoor, CFO of Avante.
Webinar Details:
TekniPlex Healthcare Brings Materials Science- Led Medical Device Solutions to Southeast Asia at Medical Fair 2026
At Booth 2C01, the company will highlight how customized medical-grade compounds, precision tubing, value-added processing, and healthcare solutions help regional OEMs develop and scale high-performance healthcare products.
At Booth 2C01, the company will highlight how customized medical-grade compounds, precision tubing, value-added processing, and healthcare solutions help regional OEMs develop and scale high-performance healthcare products.
Nova Minerals Achieves Key Milestone on Path to Antimony Production
Anchorage, Alaska, Aug. 27, 2026 (GLOBE NEWSWIRE) — Nova Minerals Corp (“Nova Minerals” or the “Company”) (NYSE American: NVA | ASX: NVA) is pleased to report that the Company has achieved a significant milestone in its efforts to establish a fully secure, vertically integrated antimony supply chain in Alaska, with the shipment of key processing and refining equipment to its Port MacKenzie plant site.
Low-rise new home sales in the GTA continue to reap the benefits of the HST rebate program in July
Toronto, Aug. 27, 2026 (GLOBE NEWSWIRE) — Low-rise new home sales in the Greater Toronto Area (GTA) continue to benefit from increased demand following the introduction of the HST rebate program, outperforming its 10-year average for a fourth consecutive month in July, the Building Industry and Land Development Association (BILD) said today. Conversely, the condominium sector has continued to struggle to fully participate in the HST rebate program as rules around construction start and completion dates limit this segment of the market.
Low-rise new home sales in the GTA continue to reap the benefits of the HST rebate program in July
Toronto, Aug. 27, 2026 (GLOBE NEWSWIRE) — Low-rise new home sales in the Greater Toronto Area (GTA) continue to benefit from increased demand following the introduction of the HST rebate program, outperforming its 10-year average for a fourth consecutive month in July, the Building Industry and Land Development Association (BILD) said today. Conversely, the condominium sector has continued to struggle to fully participate in the HST rebate program as rules around construction start and completion dates limit this segment of the market.
Four Goranson Bain Ausley Attorneys Named 2027 Best Lawyers® “Lawyer of the Year”
Goranson Bain Ausley (GBA) announced that four of its attorneys have been named 2027 Best Lawyers® “Lawyer of the Year,” with recognition spanning Family Law, Collaborative Law: Family Law and Family Law Mediation in Austin and Dallas/Fort Worth.
Goranson Bain Ausley (GBA) announced that four of its attorneys have been named 2027 Best Lawyers® “Lawyer of the Year,” with recognition spanning Family Law, Collaborative Law: Family Law and Family Law Mediation in Austin and Dallas/Fort Worth.
Rupert Grint to Reprise Film Role of “Ron Weasley” in Harry Potter and the Cursed Child on Broadway in New York City
Limited Engagement Beginning Tuesday, February 2, 2027 at New York City’s Lyric Theatre
Limited Engagement Beginning Tuesday, February 2, 2027 at New York City's Lyric Theatre
HighLife Receives CE Mark Approval for Clarity Valve, the Next-Generation Valve for the HighLife TMVR System
HighLife Receives CE Mark Approval for Clarity Valve, the Next-Generation Valve for the HighLife TMVR System
Transferra Backs John Galt Forum, with COO Alexey Reshko Joining the Panel Discussion
London, UK, Aug. 27, 2026 (GLOBE NEWSWIRE) — Transferra, a UK FCA-authorised electronic money institution, has announced its sponsorship of the John Galt Forum, taking place on 7 October 2026 at the Digital Art House in Riga.
Harmovest Capital Strengthens Global Financial Services Through Technology and Compliance
LIMASSOL, Cyprus, Aug. 27, 2026 (GLOBE NEWSWIRE) — Harmovest Capital today announced the continued development of its global financial services platform, bringing together technology, international market access, compliance and professional services within an integrated financial ecosystem. The initiative reflects the company’s focus on supporting clients and professional partners across regional markets while strengthening its capabilities in an increasingly interconnected financial landscape.
Osivax and GC Biopharma Enter Strategic Collaboration to Develop a Next-Generation Influenza Vaccine Combining OVX836 and GC FLU
Lyon, France and Yongin, Republic of Korea – 27 August 2026 – Osivax, a clinical-stage biopharmaceutical company developing differentiated influenza vaccines designed to generate broad-spectrum immune responses, and GC Biopharma, a leading South Korean biopharmaceutical company with extensive experience in vaccines and plasma-derived products, today announced a long-term collaboration to develop and commercialize a next-generation seasonal influenza vaccine candidate designed to provide broader and more durable protection against a wide range of influenza strains.